Stromal Androgen Receptor in Prostate Cancer Development and Progression
about
Clinical relevance of androgen receptor alterations in prostate cancer.Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate.Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.AR Signaling in Human Malignancies: Prostate Cancer and Beyond.Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study.Myofibroblast androgen receptor expression determines cell survival in co-cultures of myofibroblasts and prostate cancer cells in vitro.
P2860
Q42377108-8243150D-7EE9-404C-A1E6-C08F51AD8878Q45949365-2481CA53-9DA1-4945-BBC5-B979BF2558D1Q47222084-AC9C5DDA-A207-4664-BA84-16FFF8CE0FB5Q47359141-9CEA2A82-9D30-4F3B-868E-B6A70EFC9626Q48218659-FD62BEF0-F219-4FF6-B424-BB6221A53917Q48255570-6349AEB6-B30D-4837-970B-D393EF8D98A0Q55407443-DDB96970-32E6-4457-91B7-2F3AE4076A31
P2860
Stromal Androgen Receptor in Prostate Cancer Development and Progression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stromal Androgen Receptor in Prostate Cancer Development and Progression
@en
Stromal Androgen Receptor in Prostate Cancer Development and Progression.
@nl
type
label
Stromal Androgen Receptor in Prostate Cancer Development and Progression
@en
Stromal Androgen Receptor in Prostate Cancer Development and Progression.
@nl
prefLabel
Stromal Androgen Receptor in Prostate Cancer Development and Progression
@en
Stromal Androgen Receptor in Prostate Cancer Development and Progression.
@nl
P2860
P356
P1433
P1476
Stromal Androgen Receptor in Prostate Cancer Development and Progression
@en
P2093
Grant Buchanan
P2860
P356
10.3390/CANCERS9010010
P577
2017-01-22T00:00:00Z